Compile Data Set for Download or QSAR
Report error Found 120 Enz. Inhib. hit(s) with all data for entry = 11837
TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652093(US11905244, Compound 112)
Affinity DataIC50: 0.200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652068(US11905244, Compound 87)
Affinity DataIC50: 0.950nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652092(US11905244, Compound 111)
Affinity DataIC50: 1.60nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652087(US11905244, Compound 106)
Affinity DataIC50: 5.01nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652094(US11905244, Compound 113)
Affinity DataIC50: 5.83nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652096(US11905244, Compound 115)
Affinity DataIC50: 5.84nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652067(US11905244, Compound 86)
Affinity DataIC50: 6.34nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652083(US11905244, Compound 102)
Affinity DataIC50: 9.20nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652047(US11905244, Compound 66)
Affinity DataIC50: 10.5nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652077(US11905244, Compound 96)
Affinity DataIC50: 10.9nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652082(US11905244, Compound 101)
Affinity DataIC50: 11.2nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652043(US11905244, Compound 62)
Affinity DataIC50: 11.3nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652060(US11905244, Compound 79)
Affinity DataIC50: 11.7nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652034(US11905244, Compound 53)
Affinity DataIC50: 13nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652081(US11905244, Compound 100)
Affinity DataIC50: 14.8nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652084(US11905244, Compound 103)
Affinity DataIC50: 15.8nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652080(US11905244, Compound 99)
Affinity DataIC50: 18.2nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652079(US11905244, Compound 98)
Affinity DataIC50: 21.2nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652063(US11905244, Compound 82)
Affinity DataIC50: 22.4nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652045(US11905244, Compound 64)
Affinity DataIC50: 24.9nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652046(US11905244, Compound 65)
Affinity DataIC50: 30.6nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652002(US11905244, Compound 21)
Affinity DataIC50: 60.3nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652044(US11905244, Compound 63)
Affinity DataIC50: 74.4nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652050(US11905244, Compound 69)
Affinity DataIC50: 108nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM651984(US11905244, Compound 03)
Affinity DataIC50: 144nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM50534989(CHEMBL4553432 | US11905244, Compound 15)
Affinity DataIC50: 174nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652037(US11905244, Compound 56)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652036(US11905244, Compound 55)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652039(US11905244, Compound 58)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652038(US11905244, Compound 57)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652033(US11905244, Compound 52)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652032(US11905244, Compound 51)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652035(US11905244, Compound 54)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652041(US11905244, Compound 60)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652040(US11905244, Compound 59)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652042(US11905244, Compound 61)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652021(US11905244, Compound 40)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652020(US11905244, Compound 39)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652023(US11905244, Compound 42)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652017(US11905244, Compound 36)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652016(US11905244, Compound 35)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652019(US11905244, Compound 38)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652018(US11905244, Compound 37)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652029(US11905244, Compound 48)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652028(US11905244, Compound 47)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652031(US11905244, Compound 50)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652030(US11905244, Compound 49)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652025(US11905244, Compound 44)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652024(US11905244, Compound 43)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Texas A&M University System

US Patent
LigandPNGBDBM652027(US11905244, Compound 46)
Affinity DataIC50: 200nMAssay Description:Using the GFP-NFAT translocation assay method, the inhibitory activity of the selected compounds at 200 μM concentration was evaluated. As demon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

Displayed 1 to 50 (of 120 total ) | Next | Last >>
Jump to: